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Abstract
Background: Improving cardiovascular health possibly decreases the risk of dementia. Primary care practices
offer a suitable setting for monitoring and controlling cardiovascular risk factors in the older population. The
purpose of the study is to examine the association of a cardiovascular health metric including six behaviors
and blood parameters with the risk of dementia in primary care patients.
Methods: Participants (N = 3547) were insurants aged ≥55 of the largest German statutory health insurance
company, who were enrolled in a six-year prospective population-based study. Smoking, physical activity,
body mass index, blood pressure, total cholesterol, and fasting glucose were assessed by general practitioners
at routine examinations. Using recommended cut-offs for each factor, the patients’ cardiovascular health was
classified as ideal, moderate, or poor. Behaviors and blood parameters sub-scores, as well as a total score,
were calculated. Dementia diagnoses were retrieved from health insurance claims data. Results are presented
as hazard ratios (HRs) and 95 % confidence intervals (95 % CIs).
Results: Over the course of the study 296 new cases of dementia occurred. Adjusted for age, sex, and
education, current smoking (HR = 1.77, 95 % CI 1.09–2.85), moderate (1.38, 1.05–1.81) or poor (1.81, 1.32–2.47)
levels of physical activity, and poor fasting glucose levels (1.43, 1.02–2.02) were associated with an increased
risk of dementia. Body mass index, blood pressure, and cholesterol were not associated with dementia.
Separate summary scores for behaviors and blood values, as well as a total score showed no association with
dementia. Sensitivity analyses with differently defined endpoints led to similar results.
Conclusions: Due to complex relationships of body-mass index and blood pressure with dementia individual
components cancelled each other out and rendered the sum-scores meaningless for the prediction of dementia.
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Background
The number of people with dementia is expected to
increase due to the aging of the global population [1].
Along with this increase come high and rising costs
for care, rendering dementia a worldwide public
health problem [2]. In the absence of pharmacological
treatment that goes beyond symptom delay or reduc-
tion, the study of modifiable risk factors for dementia
has high priority [3]. Converging evidence points to a
central role of cardiovascular risk factors such as
physical inactivity, smoking, diabetes mellitus, midlife
hypertension, midlife obesity, and hyperlipidemia in
late-life cognitive decline [4].
Several studies suggested that substantial fractions of
dementia cases could be prevented if modifiable cardio-
vascular risk factors were targeted by intervention [5–7].
Evidence-based prevention programs, however, have
only recently been developed [8] and are far from imple-
mentation on the population level [3]. Primary care
practices might offer a suitable setting for delivering pre-
ventive measures, as they provide the facilities to assess
and control cardiovascular risk factors for dementia in
the older general population. In this context it would be
desirable to have a tool for the assessment of cardiovas-
cular health (CVH) that can be easily employed by
general practitioners (GPs) and that facilitates the com-
munication between patient and physician.
A range of CVH-metrics have been employed to pre-
dict cognitive decline and dementia [9]. Among the
more recent is the Life’s Simple 7 metric that was devel-
oped by the American Heart Association (AHA) [10].
The Life’s Simple 7 assess CVH based on seven parame-
ters: Smoking, body mass index (BMI), physical activity,
dietary habits, total cholesterol, blood pressure, and fast-
ing glucose. Cut-offs are applied to each parameter to
categorize the patients CVH-status as poor, moderate, or
ideal. Based on these classifications two sub-score for
health behaviors and blood parameters, as well as a total
score can be calculated. The simple three-step approach
has illustrative value and has been combined with a
traffic-light system in primary care to improve patient-
physician communication and track changes in CVH as
an effort to prevent stroke in primary care [11].
So far, however, only few studies investigated the rela-
tionship between the Life’s Simple 7 and cognition. Low
scores indicating poor CVH were associated with de-
creased performance on measures of cognitive function-
ing in a cross-sectional investigation [12] and predicted
incident cognitive impairment in previously unimpaired
and stroke-free persons [13]. Furthermore, high scores
indicating good CVH in young adulthood were related
to better cognitive functioning in mid-life [14]. To the
best of our knowledge, the Life’s Simple 7 have not been
used to predict dementia diagnosed according to clinical
criteria. Also, no study so far examined whether a CVH-
metric can be employed to assess dementia risk in pri-
mary care, where most older people receive their health
care and where dementia prevention programs are likely
to be implemented.
As age is the most important predictor for demen-
tia, CVH-metrics need to provide additional informa-
tion to be useful. Yet, this characteristic cannot
always be assumed. A commonly employed CVH-
metric, for example, was found to lose all predictive
validity for dementia death when age was included in
the model [15].
The aim of our study was to determine the potential
of a CVH-metric to identify individuals with increased
cardiovascular risk of dementia at routine primary care
visits. Since the data of the present study were collected
before the Life’s Simple 7 was introduced, it was not
possible to fully adhere to the criteria proposed by the
AHA. Instead, the association between scores on a
CVH-metric whose construction was based on the Life’s
Simple 7 and incident dementia was examined in a large
sample of older primary care patients. In particular, it
was investigated whether behavioral variables, blood
parameters, or a combination best captured the cardio-
vascular risk for dementia and whether possible associa-
tions are independent of age, sex, and educational level.
Methods
Participants
The present study was conducted as part of the
INVADE-trial (Intervention Project on Cerebrovascular
Disease and Dementia in the District of Ebersberg), a
prospective and population-based cohort study in a geo-
graphically defined area in southern Germany [16].
Participants were identified from the database of the
statutory health insurance company AOK (Allgemeine
Ortskrankenkasse). In Germany, membership in a health
insurance is mandatory and the AOK holds the largest
market share, representing around 40 % of the total
population. In 2001, 11,317 insurants met the inclusion
criteria of being older than 54 years, as well as living in
the district of Ebersberg, and were invited to participate.
Three-thousand nine-hundred and eight participants en-
rolled between 2001 and 2003. The observation period
ended in 2008.
Procedure
The ethics committee of the Faculty of Medicine at the
Technische Universität München approved the study
protocol and all participants signed informed consent.
The participants were examined by their GPs. The
GPs reported the patients’ previous and current diagno-
ses, current medication, alcohol consumption, physical
activity, BMI, impairment of activities of daily living
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(Rankin Scale [17]), ankle-to-brachial index, cognitive
status (6-Item Cognitive Impairment Test [18, 19]), and
conducted an electrocardiogram. Blood pressure was
measured in a supine position twice with an interval of
five minutes and a mean value was calculated. The GPs
also took fasting blood samples that were analyzed in a
central laboratory with regard to total cholesterol, low-
and high-density lipoprotein cholesterol, triglycerides,
serum glucose, glycosylated hemoglobin A1c, creatinine,
homocysteine, and high-sensitivity C-reactive protein,
and measured ankle-to-brachial index. The participants
filled in questionnaires about sociodemographic data,
depressive symptoms (Geriatric Depression Scale [20]),
use of medical services, memory complaints, and sub-
jective health. The INVADE-trial and the baseline exam-
ination are described in further detail elsewhere [16].
Cardiovascular health metric and dementia diagnoses
The CVH-metric employed in the present study is based
on the Life’s Simple 7, as they include both behavioral
and blood parameters and propose a comprehensible
and communicable scoring system. Since the data of our
study were collected before the Life’s Simple 7 was intro-
duced, it was not possible to completely adhere to the
original criteria. The Life’s Simple 7 is, hence, not dir-
ectly examined in the present study. Four adjustments
had to be made to fit the metric to the data at hand: (1)
No information about time since smoking cessation
were available; (2) dietary habits were not recorded dur-
ing the INVADE trial and therefore dropped from the
metric; (3) physical activity was assessed as number of
vigorous activities per week, not minutes per week; and
(4) antidiabetic medication was not recorded in suffi-
cient detail to be considered. Table 1 depicts the CVH-
metric employed to predict dementia.
Using the variables and cut-offs from Table 1 three in-
dices were calculated by adding up individual compo-
nent scores. (1) A health behaviors index, including
smoking, physical activity, and BMI (range 0–6). (2) A
blood parameters index, including blood pressure, total
cholesterol, and fasting glucose (range 0–6). (3) A sum
score of all individual component scores (range 0–12).
All three indices were recoded to ensure sufficient group
sizes for meaningful comparisons.
Dementia diagnoses over the course of the study were
retrieved from health insurance claims data. This
method has been shown to produce sufficiently valid
case classifications [21]. All diagnoses listed in the ICD-
10 under F00 – F03 and G30 – G31 were included. To
increase the validity of the diagnoses, the incident
dementia cases were narrowed to participants who re-
ceived respective diagnoses in at least two (not necessar-
ily consecutive) billing quarters of the statutory health
insurance or in both in- and outpatient settings, as has
been previously done in a large-scale analysis of claims
data from the same insurance company [22]. Participants
who received a diagnosis only once were excluded from
the analysis.
Statistical analyses
Cox proportional hazards regressions were employed to
estimate the risk of dementia associated with the indi-
vidual components and combined scores of the CVH-
metric. All variables were treated as categorical and for
each variable an individual model was built. Both time
variable and clinical endpoint were the same for all ana-
lyses. For incident dementia cases, the time variable was
defined by the time in month between the baseline
examination and the date of the first diagnosis according
to health insurance claims data. Cases without incident
dementia were censored at the end of observation
(change of insurance, study end, or death). All Cox pro-
portional hazards regression models were then per-
formed again with adjusting each model for age in years,
sex, and education (no formal degree; primary compul-
sory education, ≈ 8 years; higher degrees, ≥ 10 years).
Sensitivity analyses with varying definitions of the clin-
ical endpoint were calculated. First, Cox proportional
hazards regression models were built as described above.
Instead of the strict outcome variable (dementia
Table 1 Components and scoring of the cardiovascular health metric
Component Scoring
Ideal (2 points) Moderate (1 point) Poor (0 points)
Smokinga Never Quitter Current
Physical activitya ≥3 times/week 1–2 times/week inactive
Body mass indexa <25 kg/m2 25–29 kg/m2 ≥30 kg/m2
Blood pressureb SBP < 120 and DBP < 80 mmHg untreated SBP 120–139 or DBP 80–89 mmHg or
ideal but treated
SBP≥ 140 or DBP≥ 90 mmHg
Total cholesterolb <200 mg/dl untreated 200–239 mg/dl or ideal but treated ≥240 mg/dl
Fasting glucoseb <100 mg/dl 100–125 mg/dl ≥126 mg/dl
aComponents of the health behaviors index. bComponents of the blood parameters index. DBP diastolic blood pressure. SBP systolic blood pressure
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diagnoses in two billing quarters or settings), a more lib-
erally defined clinical endpoint was used (at least one
billing quarter or setting). Second, the same analyses
were performed with those cases that received only one
diagnosis (one quarter or setting) counted as non-
dementia cases instead of being excluded from the
analysis.
Results of the Cox proportional hazards regression
models are reported as hazard ratios and 95 % confi-
dence intervals. Data analysis was performed with SPSS
22 for Microsoft Windows (IBM, Armonk, New York).
Results
At baseline, 3908 participants were examined. Three-
hundred sixty-one participants were excluded from the
analysis (Fig. 1). The baseline characteristics of the in-
cluded 3547 persons are displayed in Table 2. The me-
dian observation time was 6.7 years. In total, 296 (8.3 %)
new cases of dementia occurred over the course of the
study. Most diagnoses (N = 170, 57.4 %) pertained to
“dementia not otherwise specified” (ICD-10 F03) so that
no sub-analysis for different types of dementia was
performed.
Over the course of the study, 388 patients were lost
due to death and 50 due to a change of the insurance
company. For all other cases information about incident
dementia was available until the study end. That is, for
merely 50 participants there is only limited information
about incident dementia (from start of the observation
until change of insurance).
The proportional hazards assumption was checked by
visual inspection of Kaplan-Meier estimator plots and
found to be valid. Table 3 displays the results of both
the unadjusted and adjusted Cox proportional hazards
regression models for the individual components. In the
unadjusted model, moderate and poor levels of physical
activity, as well as poor levels of fasting glucose were sta-
tistically significantly associated with an increased risk of
dementia. Poor levels of BMI, however, were associated
with a decreased risk. Adjusting for age, sex, and educa-
tion revealed significant associations of physical activity
and fasting glucose with dementia that were similar to
the unadjusted analyses, yet slightly decreased in
strength. Poor smoking behavior (i.e., current smoking)
was now associated with a significantly increased risk of
dementia, possibly due to the fact that most smokers in
the sample were of younger age. Poor BMI status was
not anymore a significant predictor, indicating a stronger
relationship of BMI with demographic variables than
with dementia. All other models remained unchanged by
the adjustment.
Table 4 displays the unadjusted and adjusted Cox pro-
portional hazards regression models for the behavioral
index, the blood parameters index, and the total score.
None of the scores was able to predict dementia, neither
with nor without adjustment. Sensitivity analyses with
varying definitions of the clinical endpoint generally
confirmed the previously established associations and,
thereby, support the validity of the original endpoint.
Using the more liberal endpoint (i.e., diagnosis only in at
least one billing quarter or setting) most associations
between CVH-variables and dementia remained un-
changed in strength and direction. Counting the 157
cases with only one diagnosis as non-dementia cases
most associations decreased in strength but retained
their direction.
Discussion
The present study investigated whether a CVH-metric
combining health behaviors and blood parameters could
Fig. 1 Participant flow chart
Table 2 Sample characteristics at baseline
Characteristics Examined at baseline
N = 3547
Age; M (SD) 67.28 (7.57)
Female; N (%) 2101 (59.2)
Education; N (%)
No formal degree 166 (4.7)
Primary compulsory 3007 (84.7)
Higher degrees 375 (10.6)
Observation time in years; median 6.7
Incident dementia; N (%) 296 (8.3)
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Table 3 Cardiovascular health components, group sizes, and dementia risk. Results of the Cox proportional hazards regressions
Cardiovascular health component scoresa Dementia/total
N
Unadjusted models
HR (95 % CI)
Adjusted modelsb
HR (95 % CI)
Smoking
2 (ideal) 214/2366 Reference Reference
1 (moderate) 61/821 0.84 (0.63–1.12) 1.15 (0.83–1.61)
0 (poor) 21/360 0.66 (0.42–1.03) 1.77 (1.09–2.85)
Physical activity
2 (ideal) 89/1672 Reference Reference
1 (moderate) 126/1384 1.80 (1.37–2.36) 1.38 (1.05–1.81)
0 (poor) 81/491 3.53 (2.61–4.76) 1.81 (1.32–2.47)
Body mass index
2 (ideal) 99/980 Reference Reference
1 (moderate) 141/1645 0.82 (0.64–1.07) 0.98 (0.76–1.28)
0 (poor) 56/922 0.58 (0.42–0.81) 0.77 (0.55–1.07)
Blood pressure
2 (ideal) 9/182 Reference Reference
1 (moderate) 122/1460 1.76 (0.90–3.47) 0.90 (0.46–1.79)
0 (poor) 165/1905 1.83 (0.93–3.57) 0.74 (0.37–1.45)
Total cholesterol
2 (ideal) 88/911 Reference Reference
1 (moderate) 130/1613 0.82 (0.63–1.08) 0.81 (0.62–1.06)
0 (poor) 78/1023 0.78 (0.58–1.06) 0.86 (0.63–1.16)
Fasting glucose
2 (ideal) 197/2511 Reference Reference
1 (moderate) 59/689 1.10 (0.82–1.47) 0.84 (0.63–1.13)
0 (poor) 40/347 1.57 (1.12–2.20) 1.43 (1.02–2.02)
Boldface indicates statistical significance at p < 0.05. aHigher scores indicate better cardiovascular health. bAdjusted for age, sex, and education. HR hazard ratio.
95 % CI 95 % confidence interval
Table 4 Cardiovascular health sum scores, group sizes, and dementia risk. Results of the Cox proportional hazards regressions
Cardiovascular health scoresa Dementia/total
N
Unadjusted models
HR (95 % CI)
Adjusted modelsb
HR (95 % CI)
Health behaviorsc
4–6 192/2315 Reference Reference
3 62/719 1.06 (0.80–1.41) 0.98 (0.73–1.31)
0–2 42/513 1.03 (0.74–1.44) 1.28 (0.91–1.80)
Blood parametersd
4–6 104/1299 Reference Reference
3 92/1174 0.98 (0.74–1.30) 0.79 (0.60–1.05)
0–2 100/1074 1.20 (0.91–1.57) 0.95 (0.72–1.25)
Total scoree
9–12 52/752 Reference Reference
5–8 212/2458 1.28 (0.95–1.74) 0.98 (0.72–1.33)
0–4 32/337 1.47 (0.94–2.28) 1.41 (0.91–2.20)
aHigher scores indicate better cardiovascular health. bAdjusted for age, sex, and education. cSum of smoking, physical activity, and body mass index. dSum of
blood pressure, total cholesterol, and fasting glucose.eSum of smoking, physical activity, body mass index, blood pressure, total cholesterol, and fasting glucose.
HR hazard ratio. 95 % CI 95 % confidence interval
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be used to identify primary care patients at cardiovascu-
lar risk of dementia and, hence, in need of medical inter-
vention. In sum, the results do not support the
suitability of the employed CVH-metric for a valid as-
sessment of the cardiovascular risk of dementia in older
primary care patients.
Employing a CVH-metric that combines several fac-
tors to assess dementia risk is only justified if the sum
scores carry predictive value that goes beyond the infor-
mation gained from the individual components. Also,
the metric should add information about dementia risk
independently of age and other demographic variables.
Both assumptions were not found to hold true for the
CVH-metric employed in the study at hand. Only the in-
dividual components smoking, physical activity, and fast-
ing glucose were significant predictors. Sub-scores for
health behaviors and blood parameters, as well as a total
score were not able to capture the cardiovascular risk of
dementia. With regard to the research question it can be
concluded that the employed metric is not suited to as-
sess the risk of dementia attributable to cardiovascular
disease in a demographically heterogeneous sample of
primary care patients.
Inspecting the demographically adjusted associations
between the individual CVH-components and dementia
reveals the problems underlying the sum-scores. Current
smoking, sedentary behavior, and impaired fasting glu-
cose were scored as reflecting poor CVH and showed
the expected relationship with an increased dementia
risk. Contrary, poor levels of BMI, blood pressure, and
total cholesterol were actually related to a (statistically
non-significant) decreased risk of dementia. By adding
the individual components into sum scores, they likely
cancelled each other out and rendered the derived scores
useless. That is, the sum scores actually masked the
valuable predictive information that is included in the
single components.
The problems encountered with the CVH-metric as
tool to assess the cardiovascular risk of dementia reflect
emerging evidence that suggests non-linear relationships
of blood pressure and BMI with dementia where age
acts as a moderating factor. While high blood pressure
at mid-life seems to increase the risk of dementia, the
association appears to reverse at late-life, when higher
levels are associated with a decreased risk [23]. The re-
sults of the study at hand support this notion. Similarly,
overweight and obesity at mid-life are assumed to in-
crease the risk of dementia [24], while a higher BMI in
late-life seems to be associated with a decreased risk
[25, 26]. In addition, the relationship of hypercholester-
olemia with dementia is somewhat ambiguous and re-
quires further investigation [27, 28], yet, the condition
would be expected to relate to an increased risk [29]. In
the study at hand, no relationship was found. The
ordinal three-step conceptualization of the CVH-metric
(poor, moderate, ideal) appears unsuited to capture
these complex associations of blood pressure, BMI, and
cholesterol with dementia. As a consequence, a CVH-
metric that might be well suited to predict, for example,
mortality [30] is likely not applicable for the assessment
of the cardiovascular risk of dementia.
Reverse causality also needs to be considered when
interpreting the results. It is possible that preclinical de-
mentia actually causes weight loss and a decrease in
blood pressure, which can be observed years before a
clinical diagnosis of dementia is made. In this case,
hypotension and underweight would rather constitute
early consequences of incipient dementia than risk fac-
tors. These potential associations might account for the
above described interaction of BMI and blood pressure
with age in the pathogenesis of dementia. When admin-
istered at only one point in time at higher age, CVH-
metrics would not be able to capture these decade-long
processes and red-flag potential underlying cognitive de-
cline. Instead, CVH-metrics needed to be administered
repeatedly starting at mid-life in order to track, for
example, progressive weight loss that might indicate in-
cipient dementia.
The CVH-metric employed in the present study
slightly deviates from the Life’s Simple 7 with regard to
the employed variables and cut-offs. Consequently, the
findings may not fully pertain to the Life’s Simple 7. The
most important difference was that diet was not in-
cluded. Even though a healthy diet seems to be associ-
ated with a decreased risk of dementia [31, 32], previous
studies found no or only weak associations between
diet and cognition in the context of the Life’s Simple
7 [12–14]. Therefore, it seems unlikely that the omis-
sion of diet significantly decreased the predictive val-
idity of the CVH-metric. Also, physical activity was
defined as vigorous activity, hence, not taking into ac-
count light or moderate activity.
Previous studies [12–14] reported stronger associa-
tions between the Life’s Simple 7 total sum score and
cognitive impairment than the association between the
CVH-metric and dementia. Next to differences in the
components of the metrics, these studies employed mea-
sures of specific cognitive functions as outcome vari-
ables. Contrary, in the present study a clinical diagnosis
of dementia was used. It is possible that others studies
found associations between poor general CVH and more
subtle cognitive changes that would not suffice to justify
a diagnosis of dementia.
If the goal is to develop a CVH-metric with high
predictive validity, it should only include components
that show unambiguous associations with dementia.
Smoking [33, 34], sedentary behavior [35, 36], and
hyperglycemia [37], are well-known to substantially
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contribute to late-life cognitive decline. Focusing on
these variables might offer a starting point for the as-
sessment and reduction of the cardiovascular risk of
dementia. Metrics could also be used to monitor
improvements in CVH. In the Life’s Simple 7, im-
proved CVH would be reflected in increasing scores.
It remains to be investigated, however, whether im-
proving scores actually translate into a decreasing
dementia risk.
The strengths of the present study include that CVH
was assessed at routine primary care examinations by
the participants’ usual GPs. The results, therefore, reflect
current possibilities to monitor and control cardiovascu-
lar risk factors in the health care system. Only for a very
small number of participants there was incomplete in-
formation about incident dementia available. This fact
reduces the possibility of bias due to non-random drop-
out. These diagnoses were made in in- and outpatient
settings according to usual clinical practice and, thereby,
increase the study’s relevance and validity in the health
care system. Some limitations had to be accepted. The
use of ICD-codes as clinical endpoints may bear the risk
of falsely classified cases. In order to reduce the possibil-
ity of overstated results due to false positives and in-
crease the validity of the endpoint, more conservative
criteria were applied to the outcome variable and sensi-
tivity analyses were conducted. False negative cases also
might have been an issue, assuming that dementia is
underdetected in community-dwelling persons. How-
ever, dementia case definitions based on health insur-
ance claims data have been shown to be sufficiently
valid [21, 22]. Two-thirds of the eligible patients did
not enroll in INVADE. Given that the study was
aimed at the identification and treatment of cardio-
vascular disease, it is possible that more health-
conscious people decided to participate. Potentially,
these persons showed better CVH than the general
older population, which might somewhat reduce the
generalizability of the study’s findings.
Conclusion
The study at hand was the first to examine the suit-
ability of a CVH-metric to assess the cardiovascular
risk of dementia for older persons at routine primary
care examinations. The metric’s sum-scores were not
associated with dementia risk and, therefore, do not
seem to be suited for that purpose. Due to complex
relationships of BMI and blood pressure with demen-
tia, individual components cancel each other out and
render the sub- and sum-scores useless. CVH-metrics
that are suitable for other purposes cannot be readily
applied for assessing the risk of dementia due to car-
diovascular disease on the population level.
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